Tofacitinib, an oral Janus kinase inhibitor, as monotherapy or with background methotrexate, in Japanese patients with rheumatoid arthritis: an open-label, long-term extension study

Hisashi Yamanaka, Yoshiya Tanaka, Tsutomu Takeuchi, +6

Arthritis Research & Therapy

Estimates of the prevalence of and current treatment practices for rheumatoid arthritis in Japan using reimbursement data from health insurance societies and the IORRA cohort (I)

Hisashi Yamanaka, Naonobu Sugiyama, Eisuke Inoue, +2

Modern Rheumatology

Malignancy risk with tofacitinib versus TNF inhibitors in rheumatoid arthritis: results from the open-label, randomised controlled ORAL Surveillance trial

Jeffrey R. Curtis, Kunihiro Yamaoka, Yi‐Hsing Chen, +9

Annals of the Rheumatic Diseases

Membranous Glomerulonephritis Development with Th2-Type Immune Deviations in MRL/<i>lpr</i> Mice Deficient for IL-27 Receptor (WSX-1)

Sakiko Shimizu, Naonobu Sugiyama, Kohsuke Masutani, +10

The Journal of Immunology

Protection against autoimmune nephritis in MyD88‐deficient MRL/lpr mice

Atsushi Sadanaga, Hitoshi Nakashima, Mitsuteru Akahoshi, +6

Arthritis & Rheumatism

Amelioration of autoimmune nephritis by imatinib in MRL/<i>lpr</i> mice

Atsushi Sadanaga, Hitoshi Nakashima, Kohsuke Masutani, +7

Arthritis & Rheumatism

Amelioration of human lupus-like phenotypes in MRL/lpr mice by overexpression of interleukin 27 receptor α (WSX-1)

Naonobu Sugiyama, Hitoshi Nakashima, Takeru Yoshimura, +10

Annals of the Rheumatic Diseases

Validity of claims‐based algorithms for selected cancers in Japan: Results from the VALIDATE‐J study

Cynthia de Luise, Naonobu Sugiyama, Toshitaka Morishima, +11

Pharmacoepidemiology and Drug Safety

CTLA-4Ig immunotherapy of obesity-induced insulin resistance by manipulation of macrophage polarization in adipose tissues

Masakazu Fujii, Toyoshi Inoguchi, Battsetseg Batchuluun, +4

Biochemical and Biophysical Research Communications

ObesityMetabolic SyndromeInflammationAutoimmune DiseaseMacrophage Polarization +13

T cell-specific overexpression of interleukin-27 receptor α subunit (WSX-1) prevents spontaneous skin inflammation in MRL/lpr mice

M. Kido, Satoshi Takeuchi, Naonobu Sugiyama, +4

British Journal of Dermatology